Introduction to 9 19 2017 Session 1 Discussion
Exploring 9 19 2017 Session 1 Discussion reveals several interesting facts. Panelists
9 19 2017 Session 1 Discussion Comprehensive Overview
MARK MCCLELLAN , Workshop Series Co-Chair Director Duke-Margolis Center for Health Policy. DANIEL FORD Director, Institute for Clinical and Translational Research Johns Hopkins School of Medicine. ELEANOR PERFETTO Senior Vice President, Strategic Initiatives National Health Council.
Panelists
Summary & Highlights for 9 19 2017 Session 1 Discussion
- JOANNE WALDSTREICHER Chief Medical Officer Johnson&Johnson.
- Andy Bindman, University of California, San Francisco.
- MICHAEL HORBERG Executive Director, Research, Community Benefit, and Medicaid Strategy Executive Director, Mid-Atlantic ...
- Panelists
- MICHAEL SHERMAN Senior VP and Chief Medical Officer Harvard Pilgrim Health Care.
Stay tuned for more updates related to 9 19 2017 Session 1 Discussion.